LipimetiX Development, LLC: Clinical Trials

1 trial sponsored by LipimetiX Development, LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow LipimetiX Development, LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia
AEM-28, Normal Saline - Hypercholesterolemia, Hyperlipoproteinemia Type II
Phase 1 / Phase 2CompletedLipimetiX Development, LLC522014-03-012015-12-29

Conditions studied

Hypercholesterolemia (1)  ·  Hyperlipoproteinemia Type II (1)

Interventions

Saline Solution (1)  ·  apolipoprotein E mimetic peptide CN-105 (1)

Countries

Australia (1)

Top investigators

Janakan Krishnarajah, MBBS, FRACP (1)